New Jersey Hematology Oncology Associates
				
				Brick, New Jersey 08724
We've found
        7 trials
        at this facility
      	
	Acute Myeloid Leukemia (AML) Clinical Trial
	
Updated: 12/31/1969
  
  
  Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With LDAC in Patients With Previously Untreated AML
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Hodgkin Lymphoma Clinical Trial
	
Updated: 12/31/1969
  
  
  A Safety Study of Growth Factor Use in Treatment With Brentuximab Vedotin Plus Chemotherapy
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Pancreatic Cancer Clinical Trial
	
Updated: 1/16/2014
  
  
  Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 1/16/2014
Click here to add this to my saved trials
	    
	 
  	
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Psychiatry / Psychology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	